Macrophage polarization in innate immune responses contributing to pathogenesis of chronic kidney disease
出版年份 2020 全文链接
标题
Macrophage polarization in innate immune responses contributing to pathogenesis of chronic kidney disease
作者
关键词
-
出版物
BMC Nephrology
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-13
DOI
10.1186/s12882-020-01921-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Zoledronic acid promotes TLR-4–mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw
- (2019) Weiwen Zhu et al. FASEB JOURNAL
- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- Macrophages: versatile players in renal inflammation and fibrosis
- (2019) Patrick Ming-Kuen Tang et al. Nature Reviews Nephrology
- M2 macrophages in kidney disease: biology, therapies, and perspectives
- (2019) Titi Chen et al. KIDNEY INTERNATIONAL
- The role of inflammasomes in kidney disease
- (2019) Takanori Komada et al. Nature Reviews Nephrology
- APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice
- (2019) Jung-Hwa Ryu et al. PLoS One
- Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases
- (2019) Theodore S. Kapellos et al. Frontiers in Immunology
- Inflammation in Renal Diseases: New and Old Players
- (2019) Vinicius Andrade-Oliveira et al. Frontiers in Pharmacology
- High Levels of IL-18 and IFN-γ in Chronically Inflamed Tissue in Chronic Granulomatous Disease
- (2019) Virginia Meda Spaccamela et al. Frontiers in Immunology
- Alterations in plasma membrane ion channel structures stimulate NLRP3 inflammasome activation in APOL1 risk milieu
- (2019) Alok Jha et al. FEBS Journal
- Inhibition of the NLRP3 inflammasome attenuates foam cell formation of THP-1 macrophages by suppressing ox-LDL uptake and promoting cholesterol efflux
- (2018) Liang Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Simultaneous activation of innate and adaptive immunity participates in the development of renal injury in a model of heavy proteinuria
- (2018) Viviane Dias Faustino et al. BIOSCIENCE REPORTS
- Metabolic regulation of macrophages in tissues
- (2018) Jan Van den Bossche et al. CELLULAR IMMUNOLOGY
- Apolipoprotein L1 nephropathies
- (2018) Jeffrey B. Kopp et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- M1/M2 macrophages in diabetic nephropathy: Nrf2/HO-1 as therapeutic targets
- (2018) R. Clive Landis et al. CURRENT PHARMACEUTICAL DESIGN
- The metabolic axis of macrophage and immune cell polarization
- (2018) Spencer A. Hobson-Gutierrez et al. Disease Models & Mechanisms
- Chronic kidney disease induces inflammation by increasing Toll-like receptor-4, cytokine and cathelicidin expression in neutrophils and monocytes
- (2018) Caren C. Grabulosa et al. EXPERIMENTAL CELL RESEARCH
- The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1–mediated tissue injury
- (2018) Hans-Joachim Anders et al. KIDNEY INTERNATIONAL
- A positive feedback loop between IL-1β, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages
- (2018) Irina Sieve et al. VASCULAR PHARMACOLOGY
- Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism
- (2018) Ryohei Kaseda et al. BMC Nephrology
- Innate immunity and Toll-like receptor signaling in the pathogenesis of scleroderma
- (2018) Max Brown et al. CURRENT OPINION IN RHEUMATOLOGY
- Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis
- (2018) Swati Bhattacharyya et al. Frontiers in Immunology
- NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development
- (2018) Patricia Ahechu et al. Frontiers in Immunology
- Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent
- (2018) Asadollah Mohammadi et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Metabolic regulation of NLRP3
- (2017) Mark M. Hughes et al. IMMUNOLOGICAL REVIEWS
- Wnt/ β -Catenin–Promoted Macrophage Alternative Activation Contributes to Kidney Fibrosis
- (2017) Ye Feng et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Relaxin abrogates renal interstitial fibrosis by regulating macrophage polarization via inhibition of Toll-like receptor 4 signaling
- (2017) Lei Chen et al. Oncotarget
- Infiltration of M1, but not M2, macrophages is impaired after unilateral ureter obstruction in Nrf2-deficient mice
- (2017) Yuji Sogawa et al. Scientific Reports
- NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy
- (2017) Yu-Ling Tsai et al. Scientific Reports
- Innate And Adaptive Immunity are Progressively Activated in Parallel with Renal Injury in the 5/6 Renal Ablation Model
- (2017) Camilla Fanelli et al. Scientific Reports
- The Origins and Functions of Tissue-Resident Macrophages in Kidney Development
- (2017) David A. D. Munro et al. Frontiers in Physiology
- Toll-like Receptor 4 Deficiency Reduces Oxidative Stress and Macrophage Mediated Inflammation in Hypertensive Kidney
- (2017) Sathnur Pushpakumar et al. Scientific Reports
- Transfusion of CD206+ M2 Macrophages Ameliorates Antibody-Mediated Glomerulonephritis in Mice
- (2016) Qiuna Du et al. AMERICAN JOURNAL OF PATHOLOGY
- The critical role of toll-like receptors — From microbial recognition to autoimmunity: A comprehensive review
- (2016) Maximiliano Javier Jiménez-Dalmaroni et al. AUTOIMMUNITY REVIEWS
- Inflammation and Progression of CKD: The CRIC Study
- (2016) R. L. Amdur et al. Clinical Journal of the American Society of Nephrology
- IL-1β promotes tubulointerstitial injury in MPO-ANCA-associated glomerulonephritis
- (2016) Manabu Tashiro et al. CLINICAL NEPHROLOGY
- Prostaglandin E2 promotes M2 polarization of macrophages via a cAMP/CREB signaling pathway and deactivates granulocytes in teleost fish
- (2016) Jana Montero et al. FISH & SHELLFISH IMMUNOLOGY
- Molecular mechanisms of regulation of Toll-like receptor signaling
- (2016) Cynthia A. Leifer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The global burden of chronic kidney disease: estimates, variability and pitfalls
- (2016) Richard J. Glassock et al. Nature Reviews Nephrology
- Regulatory T cells in immune-mediated renal disease
- (2016) Joanna R Ghali et al. NEPHROLOGY
- The NLRP3 inflammasome in kidney disease and autoimmunity
- (2016) Holly L Hutton et al. NEPHROLOGY
- Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes
- (2016) Ekta Lachmandas et al. Nature Microbiology
- Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects
- (2015) M. G. Sampson et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
- (2015) Brendan Nichols et al. KIDNEY INTERNATIONAL
- Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: Relevance to trypanosome lysis
- (2015) Russell Thomson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- APOL1 Kidney Disease Risk Variants: An Evolving Landscape
- (2015) Patrick D. Dummer et al. SEMINARS IN NEPHROLOGY
- The emerging role of the inflammasome in kidney diseases
- (2014) Anthony Chang et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Pattern recognition receptors and the inflammasome in kidney disease
- (2014) Jaklien C. Leemans et al. Nature Reviews Nephrology
- Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
- (2013) M Reilly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Renal Protective Effects of Toll-like Receptor 4 Signaling Blockade in Type 2 Diabetic Mice
- (2013) J. J. Cha et al. ENDOCRINOLOGY
- Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2
- (2013) Thimoteus Speer et al. IMMUNITY
- Human Lipopolysaccharide-binding Protein (LBP) and CD14 Independently Deliver Triacylated Lipoproteins to Toll-like Receptor 1 (TLR1) and TLR2 and Enhance Formation of the Ternary Signaling Complex
- (2013) Diana Rose E. Ranoa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Macrophage Phenotype Controls Long-Term AKI Outcomes--Kidney Regeneration versus Atrophy
- (2013) M. Lech et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Innate Immune Factor Apolipoprotein L1 Restricts HIV-1 Infection
- (2013) H. E. Taylor et al. JOURNAL OF VIROLOGY
- Increased mitochondrial activity in renal proximal tubule cells from young spontaneously hypertensive rats
- (2013) Hewang Lee et al. KIDNEY INTERNATIONAL
- Unknown
- (2013) Tarcio Braga et al. MOLECULAR MEDICINE
- Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway
- (2013) Kurt Lucas et al. MOLECULAR NEUROBIOLOGY
- Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis
- (2013) Georg Lorenz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Uric acid and chronic kidney disease: which is chasing which?
- (2013) R. J. Johnson et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9
- (2013) Ekambar R. Kandimalla et al. NUCLEIC ACIDS RESEARCH
- Interleukin-18, more than a Th1 cytokine
- (2013) Daniela Novick et al. SEMINARS IN IMMUNOLOGY
- Genetic Risk Prediction for CKD: A Journey of a Thousand Miles
- (2011) Jeffrey B. Kopp et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Knockout of Toll-Like Receptor-2 Attenuates Both the Proinflammatory State of Diabetes and Incipient Diabetic Nephropathy
- (2011) Sridevi Devaraj et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Identification of alternatively activated macrophages in new-onset paediatric and adult immunoglobulin A nephropathy: potential role in mesangial matrix expansion
- (2011) Yohei Ikezumi et al. HISTOPATHOLOGY
- APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
- (2011) J. B. Kopp et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis
- (2011) Hans-Joachim Anders et al. KIDNEY INTERNATIONAL
- Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation
- (2010) J.-C. Rodriguez-Prados et al. JOURNAL OF IMMUNOLOGY
- The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD
- (2010) A. Vilaysane et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill
- (2010) Benoit Vanhollebeke et al. MOLECULAR MICROBIOLOGY
- Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation
- (2010) M. Koc et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
- (2010) G. Genovese et al. SCIENCE
- Novel targets and new potential: developments in the treatment of inflammation in chronic kidney disease
- (2008) Csaba P Kovesdy et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- IL-18 is involved in vascular injury in end-stage renal disease patients
- (2008) T. Porazko et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started